供受者共同表达KIR配体促进异基因造血干细胞移植后NK细胞教育
该观察性研究基于两个队列(n=114和n=276),分析供受者HLA与供者抑制性KIR相互作用对单KIR+NK细胞重建的影响。移植后90–180天,供受者均表达供者抑制性KIR配体时,单KIR+NK细胞绝对数和抗K562反应性更高;供受者均表达全部三种主要KIR配体时,AML/MDS患者单倍体移植后复发率最低。
要点
- 供受者均表达供者抑制性KIR配体时,移植后NK细胞教育更优。
- NK细胞反应性与供者抑制性受体数量匹配。
- 供受者均表达全部KIR配体时AML/MDS单倍体移植复发率最低。
核心结论
- 供受者均表达供者KIR的全部配体时,重建NK细胞获得更好的功能教育,并对应最低的复发率。
研究设计与样本
- 观察性研究,两个队列分别纳入114例和276例,按供受者HLA与供者抑制性KIR的相互作用分为4组。
- 研究注册于ClinicalTrials.gov,注册号NCT02978274。
主要发现
- 移植后90–180天,供受者均表达供者抑制性KIR配体时,单KIR+NK细胞绝对数和抗K562细胞反应性(CD107a或干扰素-γ表达)高于供受者至少一方缺乏至少一种KIR配体的配对。
- NK细胞反应性与来自供者的抑制性受体数量相匹配。
- 供受者均表达三种主要KIR配体(HLA-C1、HLA-C2、HLA-Bw4)时,表达三种抑制性受体(KIR2DL1/2DL3/3DL1)的NK细胞抗K562反应性达到最高。
- 供受者均表达供者抑制性KIR全部配体时,AML和MDS患者单倍体造血干细胞移植后复发率最低。
临床怎么用
- 供受者KIR配体表达情况可作为预测异基因造血干细胞移植后NK细胞教育及白血病复发风险的参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The rate and extent of natural killer (NK)-cell education after hematopoietic cell transplantation correlates with leukemia control. To study the effect of donor and host HLA on NK-cell reconstitution, single killer-cell immunoglobulin-like receptor (KIR)+ NK cells (exhibiting KIR2DL1, KIR2DL2/KIR2DL3, or KIR3DL1 as their sole receptor) were grouped into 4 groups based on the interaction between donor/host HLA and donor inhibitory KIR in 2 cohorts (n = 114 and n = 276, respectively). On days 90 to 180 after transplantation, the absolute number and responsiveness against K562 cells (CD107a or interferon-γ expression) of single-KIR+ NK cells were higher in pairs where donor and host HLA both expressed ligands for donor inhibitory KIRs than in pairs where 1 or both of the donor and recipient HLA lacked at least 1 KIR ligand. NK-cell responsiveness was tuned commensurate with the number of inhibitory receptors from the donor. When both donor and host expressed the 3 major KIR ligands (HLA-C1, HLA-C2, and HLA-Bw4), NK cells expressing 3 inhibitory receptors (KIR2DL1/2DL3/3DL1) reached the maximum responsiveness against K562 cells compared with those NK cells expressing only 1 or 2 inhibitory receptors. When donor and host HLA both expressed all ligands for donor inhibitory KIRs, patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) showed the lowest recurrence rate after haploidentical hematopoietic stem cell transplantation (haplo-HSCT). In conclusion, this study demonstrates that when both donors and hosts present all the KIR ligands for donor KIRs, reconstituted NK cells achieve better functional education and contribute to least relapse among patients. This observation study was registered at www.clinicaltrials.gov as #NCT02978274.
引用
- Zhao XY, Yu XX, Xu ZL, et al. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2019. PMID: 31869417. doi:10.1182/bloodadvances.2019000242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。